USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PERITEC BIOSCIENCES
Address:
10000 cedar avenue
Cleveland, OH 44195-
Phone:
N/A
URL:
N/A
EIN:
154208296
DUNS:
156106952
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,278,160.00 2
SBIR Phase II $1,745,058.00 2

Award List:

Novel Biological Tissue Lined Vascular Stent Crimping and Delivery System

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$253,194.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in the United States and atherosclerosis is its major cause. Based on statistics for aging population alone, a conservative prediction is there will be approximately 190,000 peripheral vascular procedures… More

Novel Biological Tissue Lined Vascular Stent Crimping and Delivery System

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$912,042.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in the United States and atherosclerosis is its major cause. Based on statistics for aging population alone, a conservative prediction is there will be approximately 190,000 peripheral vascular procedures… More

Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$1,024,966.00
Agency:
HHS
Principal Investigator:
Don Gustavson – 216-334-4420
Abstract:
DESCRIPTION (provided by applicant): An estimated 11.5 percent of adults (approx 23 million people) suffer from chronic kidney disease. Among people suffering from ESRD, the mortality is approximately 163.8 deaths per 1,000 patient years. Hemodialysis is the leading treatment for more than 341,000… More

Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$833,016.00
Agency:
HHS
Principal Investigator:
Don Gustavson – 216-445-0961
Abstract:
DESCRIPTION (provided by applicant): An estimated 11.5 percent of adults (approx 23 million people) suffer from chronic kidney disease. Among people suffering from ESRD, the mortality is approximately 163.8 deaths per 1,000 patient years. Hemodialysis is the leading treatment for more than 341,000… More